| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | rRNA metabolic process | 1.04e-05 | 275 | 57 | 7 | GO:0016072 | |
| GeneOntologyBiologicalProcess | ribosome biogenesis | 3.76e-05 | 336 | 57 | 7 | GO:0042254 | |
| GeneOntologyCellularComponent | extrinsic component of synaptic vesicle membrane | 4.02e-05 | 25 | 56 | 3 | GO:0098850 | |
| GeneOntologyCellularComponent | Z disc | 5.22e-05 | 151 | 56 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 8.19e-05 | 166 | 56 | 5 | GO:0031674 | |
| GeneOntologyCellularComponent | extrinsic component of organelle membrane | 2.08e-04 | 43 | 56 | 3 | GO:0031312 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NOLC1 BIN1 MYBBP1A TAF3 GNL3L BRCA1 ICE2 MORF4L1 POLR1G THOC2 RFX5 PHC1 | 2.36e-04 | 1377 | 56 | 12 | GO:0140513 |
| GeneOntologyCellularComponent | sarcomere | 5.36e-04 | 249 | 56 | 5 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 8.12e-04 | 273 | 56 | 5 | GO:0030016 | |
| GeneOntologyCellularComponent | supramolecular fiber | 1.04e-03 | 1179 | 56 | 10 | GO:0099512 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.06e-03 | 290 | 56 | 5 | GO:0043292 | |
| GeneOntologyCellularComponent | supramolecular polymer | 1.09e-03 | 1187 | 56 | 10 | GO:0099081 | |
| GeneOntologyCellularComponent | Cajal body | 1.49e-03 | 84 | 56 | 3 | GO:0015030 | |
| GeneOntologyCellularComponent | presynapse | 2.36e-03 | 886 | 56 | 8 | GO:0098793 | |
| GeneOntologyCellularComponent | nuclear body | 2.65e-03 | 903 | 56 | 8 | GO:0016604 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 3.32e-03 | 32 | 56 | 2 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 3.32e-03 | 32 | 56 | 2 | GO:0043189 | |
| GeneOntologyCellularComponent | germ cell nucleus | 3.46e-03 | 113 | 56 | 3 | GO:0043073 | |
| Domain | MRG | 2.74e-05 | 3 | 57 | 2 | PS51640 | |
| Domain | MRG_dom | 2.74e-05 | 3 | 57 | 2 | IPR026541 | |
| Domain | MRG | 5.47e-05 | 4 | 57 | 2 | IPR008676 | |
| Domain | MRG | 5.47e-05 | 4 | 57 | 2 | PF05712 | |
| Domain | Syndecan | 1.90e-04 | 7 | 57 | 2 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 1.90e-04 | 7 | 57 | 2 | IPR027789 | |
| Domain | zf-C2H2_11 | 3.25e-04 | 9 | 57 | 2 | PF16622 | |
| Domain | Neurexin-like | 8.13e-04 | 14 | 57 | 2 | IPR003585 | |
| Domain | 4.1m | 8.13e-04 | 14 | 57 | 2 | SM00294 | |
| Domain | DSRM | 1.51e-03 | 19 | 57 | 2 | SM00358 | |
| Domain | dsrm | 1.68e-03 | 20 | 57 | 2 | PF00035 | |
| Domain | - | 3.06e-03 | 27 | 57 | 2 | 3.30.160.20 | |
| Domain | LisH | 3.29e-03 | 28 | 57 | 2 | SM00667 | |
| Domain | dsRBD_dom | 3.29e-03 | 28 | 57 | 2 | IPR014720 | |
| Domain | LisH | 3.29e-03 | 28 | 57 | 2 | IPR006594 | |
| Domain | LISH | 3.29e-03 | 28 | 57 | 2 | PS50896 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | TAF3 GNL3L BRCA1 MORF4L2 MORF4L1 PUM3 SYNPO BRD3 SRBD1 PHAX NOP2 TRIP12 RFX5 PHC1 | 1.39e-12 | 608 | 59 | 14 | 36089195 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NOLC1 MYBBP1A MORF4L2 STRBP PUM3 RPL14 SRBD1 PHAX POLR1G THOC2 NOP2 TRIP12 YTHDF2 NKRF | 2.65e-11 | 759 | 59 | 14 | 35915203 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOLC1 MYBBP1A RPL35A BRCA1 TCOF1 MORF4L2 MORF4L1 BRD3 RPL14 SRBD1 POLR1G THOC2 NOP2 TRIP12 RFX5 NKRF SCAF4 | 2.86e-11 | 1294 | 59 | 17 | 30804502 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NOLC1 MYBBP1A RPL35A GNL3L TCOF1 STRBP MORF4L1 PUM3 RPL14 SRBD1 POLR1G THOC2 NOP2 TRIP12 NKRF | 7.18e-11 | 989 | 59 | 15 | 36424410 |
| Pubmed | NOLC1 FOXP4 MYBBP1A RPL35A TAF3 BRCA1 MORF4L2 STRBP MORF4L1 PUM3 RPL14 NOP2 RFX5 YTHDF2 MEF2D NKRF SCAF4 | 1.33e-10 | 1429 | 59 | 17 | 35140242 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NOLC1 MYBBP1A TAF3 BRCA1 STRBP PUM3 THOC2 NOP2 TRIP12 RFX5 YTHDF2 MEF2D NKRF SCAF4 | 5.25e-10 | 954 | 59 | 14 | 36373674 |
| Pubmed | MYBBP1A TAF3 GNL3L TCOF1 STRBP OAS3 PUM3 RPL14 PHAX THOC2 NOP2 TRIP12 SDC1 YTHDF2 NKRF SCAF4 | 6.90e-10 | 1371 | 59 | 16 | 36244648 | |
| Pubmed | GNL3L BRCA1 MORF4L2 DYRK1B PUM3 BRD3 SRBD1 THOC2 NOP2 TRIP12 RFX5 PHC1 | 7.56e-10 | 645 | 59 | 12 | 25281560 | |
| Pubmed | 2.05e-09 | 417 | 59 | 10 | 36537216 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOLC1 MYBBP1A TAF3 NRXN2 TCOF1 ZNF532 MORF4L2 MORF4L1 BRD3 RPL14 THOC2 TRIP12 NKRF SCAF4 | 2.64e-09 | 1082 | 59 | 14 | 38697112 |
| Pubmed | NOLC1 RPL35A GNL3L STRBP SUPV3L1 MORF4L1 RPL14 SRBD1 NOP2 YTHDF2 NKRF PHC1 | 2.73e-09 | 723 | 59 | 12 | 34133714 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NOLC1 MYBBP1A RPL35A GNL3L SUPV3L1 OAS3 PUM3 RPL14 SRBD1 POLR1G NOP2 TRIP12 SDC1 YTHDF2 NKRF | 5.22e-09 | 1353 | 59 | 15 | 29467282 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 BIN1 MYBBP1A TAF3 TCOF1 BRD3 POLR1G THOC2 NOP2 TRIP12 MEF2D SCAF4 | 5.83e-09 | 774 | 59 | 12 | 15302935 |
| Pubmed | MYBBP1A RPL35A TCOF1 STRBP THUMPD1 OAS3 RPL14 SRBD1 PHAX NKRF | 6.29e-09 | 469 | 59 | 10 | 37314180 | |
| Pubmed | MYBBP1A BRCA1 TCOF1 MORF4L1 PUM3 SYNPO RPL14 POLR1G NOP2 NKRF SCAF4 | 8.59e-09 | 634 | 59 | 11 | 34591612 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | NOLC1 MYBBP1A RPL35A TCOF1 STRBP SUPV3L1 PUM3 RPL14 NOP2 YTHDF2 NKRF SCAF4 | 9.26e-09 | 807 | 59 | 12 | 22681889 |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 1.36e-08 | 259 | 59 | 8 | 30404004 | |
| Pubmed | MYBBP1A RPL35A GNL3L TCOF1 PUM3 BRD3 RPL14 POLR1G THOC2 NOP2 TRIP12 NKRF | 1.58e-08 | 847 | 59 | 12 | 35850772 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NOLC1 MYBBP1A RPL35A GNL3L OAS3 PUM3 SYNPO RPL14 SRBD1 THOC2 NOP2 TRIP12 YTHDF2 NKRF | 1.76e-08 | 1257 | 59 | 14 | 36526897 |
| Pubmed | MYBBP1A RPL35A STRBP RPL14 SRBD1 PHAX THOC2 NOP2 YTHDF2 NKRF SCAF4 | 2.85e-08 | 713 | 59 | 11 | 29802200 | |
| Pubmed | NOLC1 MYBBP1A SHROOM3 RPL35A TCOF1 PUM3 RPL14 POLR1G THOC2 NOP2 NKRF | 3.67e-08 | 731 | 59 | 11 | 29298432 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 MYBBP1A GNL3L TCOF1 ZNF667 RPL14 PHAX THOC2 NOP2 YTHDF2 NKRF SCAF4 | 4.60e-08 | 934 | 59 | 12 | 33916271 |
| Pubmed | 1.10e-07 | 340 | 59 | 8 | 24332808 | ||
| Pubmed | 1.40e-07 | 653 | 59 | 10 | 22586326 | ||
| Pubmed | NOLC1 FOXP4 MYBBP1A RPL35A TCOF1 PUM3 RPL14 NOP2 YTHDF2 NKRF | 1.44e-07 | 655 | 59 | 10 | 35819319 | |
| Pubmed | 1.52e-07 | 72 | 59 | 5 | 12777385 | ||
| Pubmed | SHROOM3 RPL35A GNL3L SHANK2 BRCA1 MORF4L2 MORF4L1 PUM3 BRD3 SRBD1 POLR1G SDC1 NKRF SCAF4 | 1.52e-07 | 1497 | 59 | 14 | 31527615 | |
| Pubmed | 1.71e-07 | 503 | 59 | 9 | 16964243 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 2.77e-07 | 533 | 59 | 9 | 30554943 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 3.10e-07 | 262 | 59 | 7 | 36880596 | |
| Pubmed | NOLC1 FOXP4 TAF3 GNL3L BRCA1 TCOF1 MORF4L2 MORF4L1 OAS3 BRD3 POLR1G NKRF | 3.13e-07 | 1116 | 59 | 12 | 31753913 | |
| Pubmed | HSF2BP Interacts with a Conserved Domain of BRCA2 and Is Required for Mouse Spermatogenesis. | 3.87e-07 | 9 | 59 | 3 | 31242413 | |
| Pubmed | BIN1 MYBBP1A SHROOM3 ARHGAP24 SHANK2 KIF15 TCOF1 MORF4L1 SYNPO ARMCX4 NOP2 | 5.76e-07 | 963 | 59 | 11 | 28671696 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 7.96e-07 | 605 | 59 | 9 | 28977666 | |
| Pubmed | MRG15 is a novel PALB2-interacting factor involved in homologous recombination. | 1.01e-06 | 12 | 59 | 3 | 19553677 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NOLC1 MYBBP1A TCOF1 STRBP PUM3 RPL14 THOC2 NOP2 TRIP12 NKRF SCAF4 | 1.05e-06 | 1024 | 59 | 11 | 24711643 |
| Pubmed | 1.25e-06 | 469 | 59 | 8 | 27634302 | ||
| Pubmed | 1.38e-06 | 112 | 59 | 5 | 28416769 | ||
| Pubmed | 1.48e-06 | 652 | 59 | 9 | 31180492 | ||
| Pubmed | 1.56e-06 | 483 | 59 | 8 | 36912080 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 2.03e-06 | 678 | 59 | 9 | 30209976 | |
| Pubmed | The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase. | 2.04e-06 | 220 | 59 | 6 | 34091597 | |
| Pubmed | The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival. | 2.04e-06 | 220 | 59 | 6 | 31822558 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 2.10e-06 | 349 | 59 | 7 | 25665578 | |
| Pubmed | 2.20e-06 | 223 | 59 | 6 | 20020773 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 21911940 | ||
| Pubmed | MrgX is not essential for cell growth and development in the mouse. | 2.83e-06 | 2 | 59 | 2 | 15923606 | |
| Pubmed | 2.91e-06 | 234 | 59 | 6 | 36243803 | ||
| Pubmed | MYBBP1A RPL35A GNL3L TCOF1 MORF4L2 STRBP THUMPD1 RPL14 PHAX YTHDF2 NKRF | 3.30e-06 | 1153 | 59 | 11 | 29845934 | |
| Pubmed | 3.79e-06 | 245 | 59 | 6 | 21182205 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NOLC1 MYBBP1A RPL35A GNL3L TCOF1 RPL14 POLR1G THOC2 NOP2 NKRF | 4.08e-06 | 949 | 59 | 10 | 36574265 |
| Pubmed | NOLC1 MYH7 MYBBP1A SHANK2 BRCA1 STRBP SYNPO BRD3 RPL14 SRBD1 PLCH1 TRIP12 | 4.53e-06 | 1442 | 59 | 12 | 35575683 | |
| Pubmed | MYBBP1A RPL35A TCOF1 MORF4L2 MORF4L1 RPL14 PHAX NOP2 YTHDF2 NKRF | 5.00e-06 | 971 | 59 | 10 | 33306668 | |
| Pubmed | 5.33e-06 | 260 | 59 | 6 | 36199071 | ||
| Pubmed | NOLC1 MYBBP1A TAF3 ZNF532 THUMPD1 BRD3 PHAX POLR1G THOC2 NKRF | 7.30e-06 | 1014 | 59 | 10 | 32416067 | |
| Pubmed | MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks. | 8.02e-06 | 23 | 59 | 3 | 20332121 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 11290425 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 15604408 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 8.64e-06 | 283 | 59 | 6 | 30585729 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NOLC1 MYBBP1A RPL35A TAF3 TCOF1 RPL14 POLR1G THOC2 NOP2 TRIP12 NKRF | 1.17e-05 | 1318 | 59 | 11 | 30463901 |
| Pubmed | 1.32e-05 | 305 | 59 | 6 | 21244100 | ||
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 1.61e-05 | 316 | 59 | 6 | 31665637 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 1.82e-05 | 486 | 59 | 7 | 30940648 | |
| Pubmed | 2.02e-05 | 494 | 59 | 7 | 26831064 | ||
| Pubmed | 2.09e-05 | 497 | 59 | 7 | 23414517 | ||
| Pubmed | 2.16e-05 | 197 | 59 | 5 | 32434143 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 2.21e-05 | 695 | 59 | 8 | 23602568 | |
| Pubmed | 2.35e-05 | 506 | 59 | 7 | 30890647 | ||
| Pubmed | 2.43e-05 | 340 | 59 | 6 | 29478914 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 2.47e-05 | 341 | 59 | 6 | 32971831 | |
| Pubmed | NOLC1 GNL3L STRBP OAS3 PUM3 SYNPO RPL14 THOC2 NOP2 YTHDF2 NKRF | 2.65e-05 | 1440 | 59 | 11 | 30833792 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 2.67e-05 | 714 | 59 | 8 | 28302793 | |
| Pubmed | 2.73e-05 | 347 | 59 | 6 | 17114649 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 29158494 | ||
| Pubmed | TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes. | 2.82e-05 | 5 | 59 | 2 | 22884692 | |
| Pubmed | 2.91e-05 | 103 | 59 | 4 | 32744500 | ||
| Pubmed | 3.26e-05 | 106 | 59 | 4 | 12429849 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 3.40e-05 | 361 | 59 | 6 | 30344098 | |
| Pubmed | 3.46e-05 | 37 | 59 | 3 | 7584028 | ||
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 3.75e-05 | 221 | 59 | 5 | 29991511 | |
| Pubmed | 3.94e-05 | 549 | 59 | 7 | 38280479 | ||
| Pubmed | The expression of MEF2 genes is implicated in CNS neuronal differentiation. | 4.23e-05 | 6 | 59 | 2 | 9013788 | |
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | 4.79e-05 | 384 | 59 | 6 | 31059266 | |
| Pubmed | 5.45e-05 | 43 | 59 | 3 | 7584026 | ||
| Pubmed | 5.47e-05 | 121 | 59 | 4 | 34029587 | ||
| Pubmed | BIN1 TCOF1 ZNF532 MORF4L2 SUPV3L1 MORF4L1 SYNPO ARMCX4 TRIP12 RFX5 | 5.53e-05 | 1285 | 59 | 10 | 35914814 | |
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 9891081 | ||
| Pubmed | Male fertility defect associated with disrupted BRCA1-PALB2 interaction in mice. | 5.91e-05 | 7 | 59 | 2 | 25016020 | |
| Pubmed | PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function. | 5.91e-05 | 7 | 59 | 2 | 22331464 | |
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 12391155 | ||
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 14506250 | ||
| Pubmed | 6.44e-05 | 809 | 59 | 8 | 32129710 | ||
| Pubmed | 6.85e-05 | 251 | 59 | 5 | 28077445 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 6.88e-05 | 410 | 59 | 6 | 26949251 | |
| Pubmed | 7.11e-05 | 253 | 59 | 5 | 29911972 | ||
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 7.52e-05 | 256 | 59 | 5 | 32698014 | |
| Pubmed | ChAM, a novel motif that mediates PALB2 intrinsic chromatin binding and facilitates DNA repair. | 7.87e-05 | 8 | 59 | 2 | 22193777 | |
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 23585894 | ||
| Pubmed | 8.04e-05 | 615 | 59 | 7 | 31048545 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 8.94e-05 | 430 | 59 | 6 | 38172120 | |
| Interaction | POLR1G interactions | NOLC1 MYBBP1A RPL35A TAF3 GNL3L TCOF1 STRBP PUM3 BRD3 POLR1G NOP2 TRIP12 NKRF | 1.26e-09 | 489 | 59 | 13 | int:POLR1G |
| Interaction | NIFK interactions | NOLC1 MYBBP1A TAF3 GNL3L TCOF1 PUM3 BRD3 RPL14 PHAX POLR1G NOP2 NKRF | 3.55e-09 | 431 | 59 | 12 | int:NIFK |
| Interaction | MAGEB2 interactions | MYBBP1A RPL35A BRCA1 STRBP PUM3 RPL14 SRBD1 POLR1G NOP2 NKRF SCAF4 | 4.78e-09 | 349 | 59 | 11 | int:MAGEB2 |
| Interaction | CIT interactions | NOLC1 ESYT3 MYBBP1A RPL35A BRCA1 TCOF1 MORF4L2 STRBP OAS3 PUM3 SYNPO BRD3 RPL14 SRBD1 POLR1G THOC2 NOP2 TRIP12 NKRF | 1.48e-08 | 1450 | 59 | 19 | int:CIT |
| Interaction | RPL4 interactions | NOLC1 MYBBP1A RPL35A ARHGAP24 BRCA1 PUM3 BRD3 RPL14 SRBD1 POLR1G NOP2 TRIP12 NKRF SCAF4 | 3.07e-08 | 764 | 59 | 14 | int:RPL4 |
| Interaction | MYCN interactions | NOLC1 MYBBP1A SHROOM3 RPL35A GNL3L BRCA1 TCOF1 MORF4L2 STRBP SUPV3L1 PUM3 RPL14 SRBD1 PHAX POLR1G THOC2 NOP2 NKRF | 3.95e-08 | 1373 | 59 | 18 | int:MYCN |
| Interaction | RRS1 interactions | 5.67e-08 | 345 | 59 | 10 | int:RRS1 | |
| Interaction | RPL31 interactions | NOLC1 MYBBP1A RPL35A TAF3 GNL3L BRCA1 TCOF1 STRBP PUM3 BRD3 RPL14 NOP2 NKRF | 6.35e-08 | 680 | 59 | 13 | int:RPL31 |
| Interaction | LARP7 interactions | NOLC1 MYBBP1A RPL35A GNL3L BRCA1 TCOF1 STRBP ICE2 THUMPD1 PUM3 BRD3 RPL14 SRBD1 PHAX POLR1G NKRF | 7.77e-08 | 1113 | 59 | 16 | int:LARP7 |
| Interaction | NOP56 interactions | NOLC1 MYBBP1A RPL35A GNL3L BRCA1 TCOF1 PUM3 BRD3 RPL14 POLR1G NOP2 NKRF | 7.78e-08 | 570 | 59 | 12 | int:NOP56 |
| Interaction | MECP2 interactions | NOLC1 MYBBP1A TAF3 NRXN2 TCOF1 ZNF532 MORF4L2 MORF4L1 BRD3 RPL14 SRBD1 POLR1G THOC2 NOP2 TRIP12 NKRF SCAF4 | 9.39e-08 | 1287 | 59 | 17 | int:MECP2 |
| Interaction | HECTD1 interactions | NOLC1 MYBBP1A SHROOM3 MORF4L2 STRBP PUM3 RPL14 SRBD1 PHAX POLR1G THOC2 NOP2 TRIP12 YTHDF2 NKRF | 1.02e-07 | 984 | 59 | 15 | int:HECTD1 |
| Interaction | HDLBP interactions | MYBBP1A RPL35A TAF3 GNL3L BRCA1 TCOF1 STRBP RPL14 THOC2 NOP2 SDC1 YTHDF2 NKRF SCAF4 | 1.24e-07 | 855 | 59 | 14 | int:HDLBP |
| Interaction | ZNF346 interactions | 1.30e-07 | 377 | 59 | 10 | int:ZNF346 | |
| Interaction | PRKRA interactions | MYBBP1A RPL35A BRCA1 TCOF1 STRBP PUM3 RPL14 NOP2 TRIP12 NKRF | 2.24e-07 | 400 | 59 | 10 | int:PRKRA |
| Interaction | RPS24 interactions | NOLC1 MYBBP1A RPL35A GNL3L BRCA1 STRBP PUM3 RPL14 PHAX NOP2 NKRF | 3.29e-07 | 529 | 59 | 11 | int:RPS24 |
| Interaction | RPL7A interactions | NOLC1 H1-8 MYBBP1A RPL35A BRCA1 PUM3 RPL14 PHAX POLR1G NOP2 TRIP12 NKRF | 5.09e-07 | 679 | 59 | 12 | int:RPL7A |
| Interaction | ZNF330 interactions | 6.07e-07 | 446 | 59 | 10 | int:ZNF330 | |
| Interaction | KPNA1 interactions | 7.77e-07 | 351 | 59 | 9 | int:KPNA1 | |
| Interaction | CTCF interactions | 8.20e-07 | 461 | 59 | 10 | int:CTCF | |
| Interaction | SMC5 interactions | NOLC1 MYBBP1A TAF3 BRCA1 STRBP PUM3 THOC2 NOP2 TRIP12 RFX5 YTHDF2 MEF2D NKRF SCAF4 | 8.22e-07 | 1000 | 59 | 14 | int:SMC5 |
| Interaction | MEN1 interactions | NOLC1 MYBBP1A RPL35A GNL3L TCOF1 PUM3 RPL14 SRBD1 POLR1G THOC2 NOP2 TRIP12 MEF2D NKRF | 1.16e-06 | 1029 | 59 | 14 | int:MEN1 |
| Interaction | HNRNPU interactions | MYBBP1A ARHGAP24 GNL3L BRCA1 ZNF35 MORF4L2 STRBP SUPV3L1 MORF4L1 PUM3 SRBD1 NOP2 YTHDF2 NKRF | 1.24e-06 | 1035 | 59 | 14 | int:HNRNPU |
| Interaction | H3C3 interactions | 1.56e-06 | 495 | 59 | 10 | int:H3C3 | |
| Interaction | OBSL1 interactions | NOLC1 MYBBP1A SHROOM3 TCOF1 STRBP PUM3 RPL14 POLR1G THOC2 NOP2 TRIP12 NKRF SCAF4 | 1.58e-06 | 902 | 59 | 13 | int:OBSL1 |
| Interaction | KAT6A interactions | 2.04e-06 | 510 | 59 | 10 | int:KAT6A | |
| Interaction | DDRGK1 interactions | MYBBP1A RPL35A GNL3L TCOF1 STRBP PUM3 RPL14 SRBD1 PHAX POLR1G THOC2 NOP2 TRIP12 YTHDF2 NKRF | 2.11e-06 | 1249 | 59 | 15 | int:DDRGK1 |
| Interaction | BRIX1 interactions | 2.52e-06 | 300 | 59 | 8 | int:BRIX1 | |
| Interaction | NOP58 interactions | 3.14e-06 | 309 | 59 | 8 | int:NOP58 | |
| Interaction | NOP2 interactions | 3.15e-06 | 416 | 59 | 9 | int:NOP2 | |
| Interaction | LIN28A interactions | 3.47e-06 | 421 | 59 | 9 | int:LIN28A | |
| Interaction | FTSJ3 interactions | 3.54e-06 | 422 | 59 | 9 | int:FTSJ3 | |
| Interaction | SURF6 interactions | 3.82e-06 | 426 | 59 | 9 | int:SURF6 | |
| Interaction | EBNA1BP2 interactions | 4.45e-06 | 324 | 59 | 8 | int:EBNA1BP2 | |
| Interaction | RNF113A interactions | NOLC1 FOXP4 MYBBP1A RPL35A TCOF1 PUM3 RPL14 POLR1G NOP2 YTHDF2 NKRF | 4.50e-06 | 692 | 59 | 11 | int:RNF113A |
| Interaction | HP1BP3 interactions | 4.98e-06 | 329 | 59 | 8 | int:HP1BP3 | |
| Interaction | GTPBP4 interactions | 5.24e-06 | 443 | 59 | 9 | int:GTPBP4 | |
| Interaction | CDC5L interactions | NOLC1 FOXP4 MYBBP1A SHROOM3 BRCA1 ZNF35 SUPV3L1 MORF4L1 OAS3 SYNPO THOC2 NOP2 | 5.60e-06 | 855 | 59 | 12 | int:CDC5L |
| Interaction | SRPK2 interactions | NOLC1 MYBBP1A TCOF1 PUM3 BRD3 RPL14 PHAX NOP2 TRIP12 NKRF SCAF4 | 6.31e-06 | 717 | 59 | 11 | int:SRPK2 |
| Interaction | DDX21 interactions | MYBBP1A ARHGAP24 BRCA1 KIF15 STRBP THUMPD1 PUM3 RPL14 POLR1G NOP2 NKRF | 6.40e-06 | 718 | 59 | 11 | int:DDX21 |
| Interaction | RPS6 interactions | NOLC1 H1-8 MYBBP1A RPL35A GNL3L BRCA1 STRBP PUM3 BRD3 RPL14 NOP2 NKRF | 7.00e-06 | 874 | 59 | 12 | int:RPS6 |
| Interaction | PUM3 interactions | 9.08e-06 | 254 | 59 | 7 | int:PUM3 | |
| Interaction | RPL5 interactions | NOLC1 MYBBP1A RPL35A BRCA1 TCOF1 PUM3 RPL14 POLR1G NOP2 NKRF | 9.35e-06 | 606 | 59 | 10 | int:RPL5 |
| Interaction | H3-3A interactions | TAF3 BRCA1 MORF4L2 MORF4L1 PUM3 SYNPO BRD3 SRBD1 PHAX TRIP12 RFX5 | 9.53e-06 | 749 | 59 | 11 | int:H3-3A |
| Interaction | DDX23 interactions | 9.99e-06 | 480 | 59 | 9 | int:DDX23 | |
| Interaction | ZFP62 interactions | 1.05e-05 | 99 | 59 | 5 | int:ZFP62 | |
| Interaction | ADARB1 interactions | 1.16e-05 | 489 | 59 | 9 | int:ADARB1 | |
| Interaction | LYAR interactions | 1.24e-05 | 373 | 59 | 8 | int:LYAR | |
| Interaction | EED interactions | NOLC1 MYBBP1A SHROOM3 RPL35A BRCA1 TCOF1 STRBP PUM3 RPL14 THOC2 NOP2 TRIP12 NKRF PHC1 SCAF4 | 1.25e-05 | 1445 | 59 | 15 | int:EED |
| Interaction | BRD3 interactions | 1.26e-05 | 494 | 59 | 9 | int:BRD3 | |
| Interaction | AATF interactions | 1.32e-05 | 376 | 59 | 8 | int:AATF | |
| Interaction | ZNF467 interactions | 1.38e-05 | 179 | 59 | 6 | int:ZNF467 | |
| Interaction | BRD7 interactions | NOLC1 MYBBP1A GNL3L BRCA1 STRBP BRD3 RPL14 THOC2 NOP2 YTHDF2 | 1.44e-05 | 637 | 59 | 10 | int:BRD7 |
| Interaction | FBL interactions | 1.48e-05 | 639 | 59 | 10 | int:FBL | |
| Interaction | TRRAP interactions | ESYT3 MYH7 H1-8 SHROOM3 TCOF1 MORF4L2 STRBP MORF4L1 DYRK1B POLR1G NOP2 | 1.57e-05 | 790 | 59 | 11 | int:TRRAP |
| Interaction | MKI67 interactions | 1.67e-05 | 648 | 59 | 10 | int:MKI67 | |
| Interaction | RPL11 interactions | NOLC1 MYBBP1A RPL35A BRCA1 TCOF1 PUM3 RPL14 NOP2 TRIP12 NKRF | 1.76e-05 | 652 | 59 | 10 | int:RPL11 |
| Interaction | MNDA interactions | 1.82e-05 | 188 | 59 | 6 | int:MNDA | |
| Interaction | SYN3 interactions | 1.88e-05 | 18 | 59 | 3 | int:SYN3 | |
| Interaction | DOT1L interactions | MYBBP1A RPL35A GNL3L TCOF1 PUM3 BRD3 POLR1G THOC2 NOP2 TRIP12 NKRF | 1.91e-05 | 807 | 59 | 11 | int:DOT1L |
| Interaction | PARP1 interactions | NOLC1 RPL35A TAF3 ARHGAP24 BRCA1 STRBP BRD3 RPL14 SRBD1 NOP2 TRIP12 RFX5 NKRF PHC1 | 1.98e-05 | 1316 | 59 | 14 | int:PARP1 |
| Interaction | SMCHD1 interactions | 1.99e-05 | 191 | 59 | 6 | int:SMCHD1 | |
| Interaction | NAA40 interactions | NOLC1 MYBBP1A GNL3L TCOF1 ZNF667 RPL14 PHAX THOC2 NOP2 YTHDF2 NKRF SCAF4 | 2.16e-05 | 978 | 59 | 12 | int:NAA40 |
| Interaction | RPL15 interactions | 2.19e-05 | 530 | 59 | 9 | int:RPL15 | |
| Interaction | SNRNP70 interactions | MYBBP1A RPL35A ARHGAP24 STRBP RPL14 SRBD1 PHAX THOC2 NOP2 YTHDF2 NKRF SCAF4 | 2.29e-05 | 984 | 59 | 12 | int:SNRNP70 |
| Interaction | PHIP interactions | 2.37e-05 | 197 | 59 | 6 | int:PHIP | |
| Interaction | CAMKV interactions | 2.46e-05 | 118 | 59 | 5 | int:CAMKV | |
| Interaction | RPL8 interactions | 2.50e-05 | 539 | 59 | 9 | int:RPL8 | |
| Interaction | KPNB1 interactions | 2.69e-05 | 544 | 59 | 9 | int:KPNB1 | |
| Interaction | SNIP1 interactions | 2.77e-05 | 417 | 59 | 8 | int:SNIP1 | |
| Interaction | MTF1 interactions | 3.00e-05 | 123 | 59 | 5 | int:MTF1 | |
| Interaction | ABT1 interactions | 3.06e-05 | 423 | 59 | 8 | int:ABT1 | |
| Interaction | RPL10 interactions | MYBBP1A RPL35A GNL3L BRCA1 MORF4L1 PUM3 RPL14 PHAX NOP2 YTHDF2 | 3.31e-05 | 702 | 59 | 10 | int:RPL10 |
| Interaction | RPL26L1 interactions | 3.50e-05 | 431 | 59 | 8 | int:RPL26L1 | |
| Interaction | SRCAP interactions | 3.50e-05 | 127 | 59 | 5 | int:SRCAP | |
| Interaction | RNF2 interactions | NOLC1 MYBBP1A STRBP MORF4L1 PUM3 RPL14 POLR1G THOC2 NOP2 YTHDF2 PHC1 | 3.66e-05 | 866 | 59 | 11 | int:RNF2 |
| Interaction | ZC3H18 interactions | NOLC1 MYBBP1A SHROOM3 RPL35A TCOF1 PUM3 RPL14 POLR1G THOC2 NOP2 NKRF | 4.10e-05 | 877 | 59 | 11 | int:ZC3H18 |
| Interaction | RPL3 interactions | H1-8 MYBBP1A RPL35A BRCA1 PUM3 RPL14 POLR1G NOP2 TRIP12 NKRF | 4.20e-05 | 722 | 59 | 10 | int:RPL3 |
| Interaction | RPF1 interactions | 4.21e-05 | 132 | 59 | 5 | int:RPF1 | |
| Interaction | POLR1A interactions | 4.40e-05 | 220 | 59 | 6 | int:POLR1A | |
| Interaction | RCHY1 interactions | 4.42e-05 | 325 | 59 | 7 | int:RCHY1 | |
| Interaction | NOLC1 interactions | 4.42e-05 | 325 | 59 | 7 | int:NOLC1 | |
| Interaction | RPL18A interactions | 4.53e-05 | 447 | 59 | 8 | int:RPL18A | |
| Interaction | KLF8 interactions | 4.78e-05 | 329 | 59 | 7 | int:KLF8 | |
| Interaction | CAND1 interactions | MYBBP1A RPL35A ARHGAP24 BRCA1 TCOF1 STRBP RPL14 PHAX NOP2 YTHDF2 NKRF | 4.89e-05 | 894 | 59 | 11 | int:CAND1 |
| Interaction | NLE1 interactions | 5.36e-05 | 228 | 59 | 6 | int:NLE1 | |
| Interaction | CDK12 interactions | 5.36e-05 | 228 | 59 | 6 | int:CDK12 | |
| Interaction | LLPH interactions | 5.39e-05 | 139 | 59 | 5 | int:LLPH | |
| Interaction | SIRT7 interactions | 5.41e-05 | 744 | 59 | 10 | int:SIRT7 | |
| Interaction | ARL4D interactions | 6.81e-05 | 146 | 59 | 5 | int:ARL4D | |
| Interaction | PML interactions | NOLC1 MYBBP1A BRCA1 ICE2 OAS3 SYNPO RPL14 THOC2 NOP2 YTHDF2 MEF2D | 7.18e-05 | 933 | 59 | 11 | int:PML |
| Interaction | RNF169 interactions | 7.26e-05 | 76 | 59 | 4 | int:RNF169 | |
| Interaction | CHD4 interactions | NOLC1 MYBBP1A GNL3L TCOF1 STRBP PUM3 BRD3 RPL14 NOP2 TRIP12 NKRF | 7.53e-05 | 938 | 59 | 11 | int:CHD4 |
| Interaction | TAF1A interactions | 8.04e-05 | 78 | 59 | 4 | int:TAF1A | |
| Interaction | MAFB interactions | 8.16e-05 | 246 | 59 | 6 | int:MAFB | |
| Interaction | RPL32 interactions | 8.70e-05 | 362 | 59 | 7 | int:RPL32 | |
| Interaction | RPL6 interactions | 9.11e-05 | 637 | 59 | 9 | int:RPL6 | |
| Interaction | SNRNP40 interactions | 9.11e-05 | 637 | 59 | 9 | int:SNRNP40 | |
| Interaction | RPL28 interactions | 9.11e-05 | 494 | 59 | 8 | int:RPL28 | |
| Interaction | EIF6 interactions | 9.16e-05 | 365 | 59 | 7 | int:EIF6 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 2.51e-04 | 12 | 36 | 2 | 1243 | |
| GeneFamily | L ribosomal proteins | 4.62e-03 | 51 | 36 | 2 | 729 | |
| GeneFamily | Sterile alpha motif domain containing | 1.33e-02 | 88 | 36 | 2 | 760 | |
| Coexpression | HALLMARK_MYC_TARGETS_V2 | 1.86e-07 | 58 | 58 | 5 | M5928 | |
| Coexpression | BILD_MYC_ONCOGENIC_SIGNATURE | 6.85e-06 | 209 | 58 | 6 | M2069 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | NOLC1 FOXP4 MYBBP1A SHROOM3 KIF15 NRXN2 TCOF1 PUM3 RPL14 PLCH1 POLR1G NOP2 NKRF SCAF4 | 2.50e-07 | 991 | 57 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | NOLC1 MYBBP1A SHROOM3 BRCA1 ZNF35 KIF15 TCOF1 ICE2 PUM3 PLCH1 PHAX POLR1G NOP2 NKRF SCAF4 | 2.78e-07 | 1164 | 57 | 15 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NOLC1 BRCA1 SYN3 KIF15 NRXN2 TCOF1 STRBP ICE2 PUM3 PLCH1 POLR1G NKRF SCAF4 | 1.63e-06 | 989 | 57 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | NOLC1 MYBBP1A SHROOM3 BRCA1 ZNF35 KIF15 TCOF1 ICE2 PUM3 PLCH1 PHAX POLR1G NOP2 NKRF SCAF4 | 1.76e-06 | 1347 | 57 | 15 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | NOLC1 MYBBP1A SHROOM3 GNL3L SHANK2 BRCA1 KIF15 TCOF1 PUM3 PLCH1 PHAX POLR1G NOP2 NKRF SCAF4 | 2.19e-06 | 1371 | 57 | 15 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#4 | NOLC1 MYBBP1A TCOF1 SUPV3L1 PUM3 RPL14 SRBD1 POLR1G NOP2 SCAF4 | 3.24e-06 | 587 | 57 | 10 | Facebase_RNAseq_e8.5_Floor Plate_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.09e-05 | 285 | 57 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | NOLC1 GNL3L SHANK2 BRCA1 KIF15 TCOF1 STRBP SUPV3L1 ICE2 PHAX THOC2 NKRF PHC1 | 2.19e-05 | 1257 | 57 | 13 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500 | 5.07e-05 | 496 | 57 | 8 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 9.02e-05 | 169 | 57 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NOLC1 GNL3L SHANK2 BRCA1 KIF15 TCOF1 STRBP SUPV3L1 ICE2 PHAX THOC2 NKRF PHC1 | 1.02e-04 | 1459 | 57 | 13 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | skeletal muscle | 2.13e-04 | 320 | 57 | 6 | skeletal muscle | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.22e-04 | 205 | 57 | 5 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K5 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | 2.48e-04 | 795 | 57 | 9 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | 2.85e-04 | 810 | 57 | 9 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#1 | 3.77e-04 | 127 | 57 | 4 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K1 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.02e-04 | 376 | 57 | 6 | gudmap_developingKidney_e11.5_metaneph mesench_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.39e-04 | 533 | 57 | 7 | gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#4_top-relative-expression-ranked_200 | 6.31e-04 | 14 | 57 | 2 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_200_k4 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.28e-07 | 195 | 59 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.28e-07 | 195 | 59 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-HSC/MPP_and_pro-LMPP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.02e-06 | 156 | 59 | 5 | 331b63bf4744ab494c3959436a8a0d8a1e4c0de4 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 6.17e-06 | 196 | 59 | 5 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-05 | 149 | 59 | 4 | 7e295b2b82dea0754e98f8cef788e2781e5d641f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-05 | 149 | 59 | 4 | b4f77dc5f9d08b249fe5cd9a0acf86308c528ef4 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.11e-05 | 167 | 59 | 4 | a54b8e03987a7b067173121902e1811a3d003692 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.79e-05 | 171 | 59 | 4 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | COVID-19_Mild-PLT_2|COVID-19_Mild / Disease Group and Platelet Clusters | 8.15e-05 | 173 | 59 | 4 | d11705e56b6b21eec963ea224717f27680c781ed | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 173 | 59 | 4 | 15af4a0f7516dbf5c93ba66a19aca073ebe30d04 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.33e-05 | 174 | 59 | 4 | ccc79febfcf588d8294ffc712338be96de8a5033 | |
| ToppCell | (1)_B_cell-(100)_CD19+_Naive_B_cell|(1)_B_cell / immune cells in Peripheral Blood (logTPM normalization) | 8.71e-05 | 176 | 59 | 4 | 08bf8485422fce1a4a3b1e7f6b9fab735ce61d46 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-RGCs_early_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 8.71e-05 | 176 | 59 | 4 | 2a15437c5f5dbf6398d5ea70050632c24a7dc66c | |
| ToppCell | (1)_B_cell-(10)_B_cell-(100)_CD19+_Naive_B_cell|(10)_B_cell / immune cells in Peripheral Blood (logTPM normalization) | 8.71e-05 | 176 | 59 | 4 | 184f46f01d30630e4bc14eaefb3de9e2a147ccd4 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.10e-05 | 178 | 59 | 4 | 5d41fede13c8e64b6fdaf2155f1eb72bcfc32fdb | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.29e-05 | 179 | 59 | 4 | 23e2ec64ff8384c29b9c0abfb05c4694a37c6a8e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.70e-05 | 181 | 59 | 4 | 098dbb3e0ff531c9720a233123250c1e39a97d4c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.70e-05 | 181 | 59 | 4 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | normal-na-Lymphocytic_B-B_mem-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 9.91e-05 | 182 | 59 | 4 | ee36ea6cb9a5a08aeb83f2b7a249255f0b1a9870 | |
| ToppCell | severe_influenza-B_intermediate|World / disease group, cell group and cell class (v2) | 9.91e-05 | 182 | 59 | 4 | e633a908a2fb30ed362cf22fbb8d6839f31f1751 | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-04 | 184 | 59 | 4 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-04 | 185 | 59 | 4 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-04 | 185 | 59 | 4 | 8ca1374501eca01d8468130b74d50abfd4329fbe | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.08e-04 | 186 | 59 | 4 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-04 | 186 | 59 | 4 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | Healthy_donor-B_memory|World / disease group, cell group and cell class (v2) | 1.10e-04 | 187 | 59 | 4 | 4f68e3243071a4549c80aff8bff32c6ad892ee7f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-B_cell-B_cell-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.10e-04 | 187 | 59 | 4 | 4f79b36c07efd3d6a2fa7220269cabeec11157df | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-04 | 188 | 59 | 4 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.12e-04 | 188 | 59 | 4 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory-B_memory-0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.12e-04 | 188 | 59 | 4 | 229108e7e3db49e1cfd747d69e338394139d95b3 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 188 | 59 | 4 | b2472a294b25fc2f0da7f18519fdcb9ca166c6f0 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 188 | 59 | 4 | bf77e59b9001c7f7ca17f81073f935f281a25a1f | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 189 | 59 | 4 | b81540e097e95158851e07bfd78640ed6e64c2cf | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 189 | 59 | 4 | 0fda1a3f1e87fadf5309c8267beaa4501983b1dd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.17e-04 | 190 | 59 | 4 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.17e-04 | 190 | 59 | 4 | 441770ce7b3c81f36f5b15b8e51794f736462457 | |
| ToppCell | B_cell_maturation|World / Lineage and Cell class | 1.17e-04 | 190 | 59 | 4 | 301782283d0c604fb3b428a8ddf1f7cd8e63a90b | |
| ToppCell | ILEUM-inflamed-(2)_Naive_B_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.17e-04 | 190 | 59 | 4 | a08d10f8145247d16c952a6f83957f5b57c6940b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 190 | 59 | 4 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.19e-04 | 191 | 59 | 4 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | metastatic_Brain-B_lymphocytes-Follicular_B_cells|metastatic_Brain / Location, Cell class and cell subclass | 1.19e-04 | 191 | 59 | 4 | f400fce79aacf029e20b6dca59d3e17bb2375f28 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.19e-04 | 191 | 59 | 4 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | (100)_CD19+_Naive_B_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 1.22e-04 | 192 | 59 | 4 | ae7e6ed7b6cc1dd45bc0547783515beecad7792a | |
| ToppCell | Healthy-B_naive|Healthy / disease group, cell group and cell class | 1.22e-04 | 192 | 59 | 4 | 5fddf679dcc9c0077d6bfe04c1e602863fb959eb | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 192 | 59 | 4 | 5155f746ad57122ef735da776c96721005b8dadc | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-04 | 192 | 59 | 4 | ef86d82e4f04f9f54e821ef496d70fc81072d773 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 1.22e-04 | 192 | 59 | 4 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 193 | 59 | 4 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.27e-04 | 194 | 59 | 4 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-04 | 194 | 59 | 4 | dcf1b66f20ee9fe86de71221a086742140aa07d8 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.29e-04 | 195 | 59 | 4 | 820250198c787223eb4e073db11a983851ddcdd2 | |
| ToppCell | severe-B_intermediate|World / disease stage, cell group and cell class | 1.29e-04 | 195 | 59 | 4 | ce4bd004ceb05a269387adfed255d7fa393afcc6 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-Naive_B|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-04 | 195 | 59 | 4 | 537ca6df3a44bfde83c137f0c808a595c3dad892 | |
| ToppCell | COVID-19_Severe-B_memory|COVID-19_Severe / disease group, cell group and cell class | 1.29e-04 | 195 | 59 | 4 | 54becd9e283639638fc5f13eddce224aed9391da | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.29e-04 | 195 | 59 | 4 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | Healthy_donor-B_naive|World / disease group, cell group and cell class (v2) | 1.29e-04 | 195 | 59 | 4 | c66bbfdf0091cc62aa50edfa88820bbda191b7bb | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 1.29e-04 | 195 | 59 | 4 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | Healthy/Control-B_naive|Healthy/Control / Disease group and Cell class | 1.32e-04 | 196 | 59 | 4 | e92d2c814d2dcb049f3e455fe66fd40898b3524d | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Follicular_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.32e-04 | 196 | 59 | 4 | d9951569068ad346a0764fe3bafff43e9f409992 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-GC_B_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-04 | 196 | 59 | 4 | d08f6143d148a897efacc854e4306455a9a9868c | |
| ToppCell | severe_COVID-19-B_memory|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.32e-04 | 196 | 59 | 4 | c6e00cb59a88b9903cca233cefe05f80c5ea4153 | |
| ToppCell | Healthy_donor-B_naive|Healthy_donor / disease group, cell group and cell class (v2) | 1.32e-04 | 196 | 59 | 4 | cf254b1466357984201595fa32408d659eb741ef | |
| ToppCell | severe-Lymphocytic-B_cells_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.32e-04 | 196 | 59 | 4 | 07651cac8a17c18dfa4e9c20cbf699fee2146145 | |
| ToppCell | severe-B_intermediate|severe / disease stage, cell group and cell class | 1.32e-04 | 196 | 59 | 4 | 8f59e51ca50bef4753f67cd1efdb02665805a120 | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.34e-04 | 197 | 59 | 4 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | COVID-19_Severe-Lymphoid_B|COVID-19_Severe / Disease group, lineage and cell class | 1.34e-04 | 197 | 59 | 4 | 25303329b051831cf2ed4df68f3948308e5fbd96 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.34e-04 | 197 | 59 | 4 | 5c67ed18fb92aec73c79f4db6d80cec777d9ba44 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.34e-04 | 197 | 59 | 4 | 368a7908435cb0d0feea135345e7179584a1e0cf | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 197 | 59 | 4 | 87d09f53b84af482116d3e2076eab1a9e555a2a6 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 197 | 59 | 4 | 5bf5187fcba4ccc3f83bc9e884e40ff344a3d109 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-CD4+_CTL|Influenza_Severe / Disease, condition lineage and cell class | 1.34e-04 | 197 | 59 | 4 | 8610307434d99e6411a5a6c6769094e9a0749d4d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 197 | 59 | 4 | eb119e048d5ea1be5f427bb9fb60e5e7b6e84d92 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 197 | 59 | 4 | b1c6a15bf6c0645952a7247182dc71baf4736869 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.37e-04 | 198 | 59 | 4 | c477405b093f4e5374e57bcacf1fb204a0f7eb3b | |
| ToppCell | Severe-B_intermediate-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.37e-04 | 198 | 59 | 4 | c073281c7f9bb6062449c75b4ace4d54b866a33e | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_late|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.37e-04 | 198 | 59 | 4 | 1851b7f4198b42c21c934e2fbda39dbd65e2625c | |
| ToppCell | Severe-B_memory-0|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.37e-04 | 198 | 59 | 4 | 9cc75d14f1220fe15e530115f6dff09c31f07f7c | |
| ToppCell | wk_15-18-Epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.37e-04 | 198 | 59 | 4 | 12bbe77c3d68bf1e545949dbb1eb49ed3641de3d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-04 | 198 | 59 | 4 | 3675e0dfd8d8428ba76f7a6644069f05a087febd | |
| ToppCell | mild-B_memory|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.40e-04 | 199 | 59 | 4 | e6ac9a0959b0de2c6a99298feb7715aa80ade1dd | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-04 | 199 | 59 | 4 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-04 | 199 | 59 | 4 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-04 | 199 | 59 | 4 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.40e-04 | 199 | 59 | 4 | 92fdf6e2f0786ab2ab78126e9131a93794168139 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-B_lymphocytic-memory_B_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.40e-04 | 199 | 59 | 4 | 38747e07853f60d11eda9371cf5e6493e21a9cc3 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-B_memory|COVID-19_Severe / Disease, condition lineage and cell class | 1.40e-04 | 199 | 59 | 4 | 24c05faa825c9d55279956469862440f9914a280 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_naive|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-04 | 199 | 59 | 4 | 8bc07beace200ae2ad41e932b72fdcc7ff08b812 | |
| ToppCell | Transverse-(2)_B_cell-(22)_B_cell_memory|Transverse / shred on region, Cell_type, and subtype | 1.42e-04 | 200 | 59 | 4 | e42c393b63d3f854c898d0a559dd96f8c2caa4c2 | |
| ToppCell | Transverse-B_cell-B_cell_memory|Transverse / Region, Cell class and subclass | 1.42e-04 | 200 | 59 | 4 | 5808dc2fdb9275b3e97bc40a3b0ffa7b63e61166 | |
| ToppCell | Transverse-B_cell-B_cell_memory|B_cell / Region, Cell class and subclass | 1.42e-04 | 200 | 59 | 4 | a92b5f883d95b6a3db8ceccf294aa503839f7ed3 | |
| ToppCell | Severe-B_intermediate-0|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.42e-04 | 200 | 59 | 4 | da37ca52b0121ab0fb6ae69626de51350e979a6a | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Follicular_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.42e-04 | 200 | 59 | 4 | f08532a1a4ebf9ac6c7058a6591afd11df7e94f0 | |
| ToppCell | PBMC-Severe-cDC_1|Severe / Compartment, Disease Groups and Clusters | 1.70e-04 | 81 | 59 | 3 | 6d1e524f000b71c935359afc801a1d31f218fec8 | |
| ToppCell | Control-NK_activated|Control / Disease condition and Cell class | 5.26e-04 | 119 | 59 | 3 | 0d0bab03d56e269c6e637b0bbeffe9d1491dfc33 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.25e-04 | 28 | 59 | 2 | 456cf2e0a6ea59c279efc77a1d02e5572196cb6b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.81e-04 | 130 | 59 | 3 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_immature_4|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.81e-04 | 130 | 59 | 3 | 169d88bffd7cd813a484d809defa638ceaca4bcb | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma-4|TCGA-Uterus / Sample_Type by Project: Shred V9 | 6.96e-04 | 131 | 59 | 3 | 1801611e6b63aa07629e7ccc692f45a7e93c8dd8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.27e-04 | 133 | 59 | 3 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Acta2Rgs5.Rgs5_(Mural.Acta2Rgs5.Rgs5)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.43e-04 | 134 | 59 | 3 | 1fa13185a4dfb4563473184c0c4f449011d88631 | |
| Disease | Treacher Collins syndrome (implicated_via_orthology) | 5.28e-05 | 6 | 56 | 2 | DOID:2908 (implicated_via_orthology) | |
| Disease | Focal Segmental Glomerulosclerosis, Not Otherwise Specified | 1.26e-04 | 9 | 56 | 2 | C4049702 | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 1.58e-04 | 10 | 56 | 2 | cv:C5675009 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.02e-04 | 152 | 56 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Autosomal Dominant Myotubular Myopathy | 2.72e-04 | 13 | 56 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 2.72e-04 | 13 | 56 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 2.72e-04 | 13 | 56 | 2 | C0410203 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.72e-04 | 13 | 56 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Congenital Structural Myopathy | 2.72e-04 | 13 | 56 | 2 | C0752282 | |
| Disease | Myopathy, Centronuclear, 1 | 2.72e-04 | 13 | 56 | 2 | C4551952 | |
| Disease | aspartate aminotransferase measurement | 2.91e-04 | 904 | 56 | 8 | EFO_0004736 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 3.17e-04 | 14 | 56 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 3.17e-04 | 14 | 56 | 2 | C0410207 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 3.66e-04 | 15 | 56 | 2 | C3645536 | |
| Disease | Hodgkins lymphoma | 5.16e-04 | 82 | 56 | 3 | EFO_0000183 | |
| Disease | Congenital Fiber Type Disproportion | 5.31e-04 | 18 | 56 | 2 | C0546264 | |
| Disease | major depressive disorder, COVID-19 | 1.12e-03 | 26 | 56 | 2 | MONDO_0002009, MONDO_0100096 | |
| Disease | Limb-girdle muscular dystrophy | 1.12e-03 | 26 | 56 | 2 | cv:C0686353 | |
| Disease | serum alanine aminotransferase measurement | 1.24e-03 | 869 | 56 | 7 | EFO_0004735 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IKKVATNQGPKAQPQ | 606 | A0FGR9 | |
| AKVAPPAKQAQQKKA | 521 | Q15059 | |
| AQQAPPQDSSNKKEK | 71 | Q9Y463 | |
| LPGAKNKVKANLNAV | 761 | Q5H9R4 | |
| LPGAKNKVKGNPNVV | 841 | Q5H9R4 | |
| NKVKGNPNVVSKAGA | 846 | Q5H9R4 | |
| VQKGVKPQAKAAKAP | 146 | Q14978 | |
| ASGQAPPAKAAKQDI | 441 | P48382 | |
| KQQGDKSPKNKFQPA | 71 | Q15397 | |
| ANFQKPRNIKGKPEA | 561 | P12883 | |
| AAPGKKTSGLQQKNV | 131 | Q9UBU8 | |
| AKAPKAGQGPNTKAA | 286 | Q8IZA3 | |
| DKNQQGFSPKAQKEP | 561 | Q9NS87 | |
| KILSPNGGKPKAINQ | 151 | Q6IB77 | |
| KKTAGPQQKNLEPAL | 41 | Q15014 | |
| QTQKAKRKAQFAAPP | 331 | Q16445 | |
| QQAGKPQPKEALGNK | 161 | Q8IVH2 | |
| LQKKNQKPSQVNGAP | 1251 | Q9BQG0 | |
| QSNGAVVKEKAPAAP | 636 | P58401 | |
| KKNPAFNKGSGIVTN | 421 | Q8N264 | |
| KTKGDSIQNEKNPNP | 556 | P38398 | |
| AKIPANSKAVGINKN | 116 | Q659A1 | |
| PGDKQKSYQGQSPQK | 221 | Q5T1N1 | |
| PQTKNKADLQDGKAP | 131 | A0A1B0GTZ2 | |
| AGQAPQQKTQAKPTK | 16 | A6NKP2 | |
| VKAQPSDNAPAKGNK | 281 | O00499 | |
| KGIPKKPENEVAQNG | 631 | O95104 | |
| PVANGNSLNKVIPAK | 236 | Q14814 | |
| QSSQKPPVAGGKKIN | 101 | Q9H814 | |
| QVAAQNKGKGPAPAS | 611 | Q9Y6K5 | |
| PDAGKLNSENQPKKA | 366 | Q5VWG9 | |
| APQIKSAKSPGQAQL | 411 | O14994 | |
| YKAKNNTVTPGGKPN | 51 | P18077 | |
| AMNAAQVKPLGKSPQ | 491 | Q13428 | |
| TCDGQNPPKKQAGSK | 36 | O15226 | |
| QAKPKPKPNQNLSEA | 706 | Q8N3V7 | |
| PQPAKQNGKKATSKV | 26 | Q9NVN8 | |
| GAKPQAQAALAAPKK | 371 | O15446 | |
| VKPKHNYTQKAQPGQ | 446 | Q8TF72 | |
| PKQANGGAYQKPTKQ | 291 | P18827 | |
| SGPNAANNKKKKIIP | 576 | Q96SI9 | |
| PGTKLAQAKKFNDPN | 401 | Q8IYB8 | |
| EKAAFQKQNDTPKGP | 766 | P46087 | |
| QGQPVKFPANANSTK | 191 | Q8N5C6 | |
| QQGPKGEAPKADLNK | 1231 | Q9UPX8 | |
| ETKKLPPNQCNKSGQ | 91 | Q5HYK9 | |
| NSGAVKNPKTQLGQK | 206 | P13682 | |
| HKLKEPQPVSKQNGA | 1226 | Q9HCE3 | |
| PKGAKGSPVNALQNK | 401 | Q8NI27 | |
| KKAPAQKVPAQKATG | 171 | P50914 | |
| QKVPAQKATGQKAAP | 176 | P50914 | |
| QKATGQKAAPAPKAQ | 181 | P50914 | |
| QKAAPAPKAQKGQKA | 186 | P50914 | |
| APKAQKGQKAPAQKA | 191 | P50914 | |
| KKAQKESPLPGQANG | 221 | Q5T0D9 | |
| KPPQLGAAKMSAAQQ | 506 | P78364 | |
| KQEANKQKVPNPSNG | 1596 | Q4KWH8 | |
| KKQQQIPNPSGKFDG | 301 | Q658L1 | |
| KAPGEQQKLQGNPTK | 1011 | Q502W6 | |
| APQPGQQKKLAVFSK | 36 | A8MV65 | |
| VPPGARVKQGKDQNK | 216 | Q14669 | |
| PKDPSQLNSKQGNGK | 271 | Q9NXG2 | |
| PAKQQPKLKTKNGIA | 246 | Q9Y5A9 | |
| KGPVAKAPSQALVQN | 281 | Q9Y5A9 | |
| GQPINAKPSQTANAK | 126 | Q9UBF9 | |
| AKKNTKSPQPVNDDN | 861 | Q86TC9 |